or Try an Advanced Search...

    Overactive Bladder Stocks List

    Symbol Grade Name % Change
    MDT C Medtronic Inc. 0.10
    URGN F UroGen Pharma Ltd. -1.77
    View As Page of Charts
    Related Industries: Biotechnology Medical Devices
    Related Stock Lists: Medicine Ablation Ablation Products Advanced Energy Antineoplastic Drugs Atrial Fibrillation Biologic Product Biologic Products Biopharmaceutical Bladder Cancer Bone Botulinum Toxin Bypass Cancer Carcinoma Cardiac Electrophysiology Catheter Chemotherapy Chronic Pain Cordis

    Related ETFs - A few ETFs which own one or more of the above listed Overactive Bladder stocks.

    Symbol Grade Name Weight
    FLV A American Century Focused Large Cap Value ETF 5.45
    IHI D iShares U.S. Medical Devices ETF 4.98
    ABEQ A Absolute Core Strategy ETF 4.53
    MVAL A SHL Telemedicine Ltd VanEck Morningstar Wide Moat Value ETF 3.91
    LBAY A Leatherback Long/Short Alternative Yield ETF 3.78
    View all Overactive Bladder ETFs...
    Compare ETFs
    Compare FLV to ABEQ Compare FLV to MVAL Compare MVAL to LBAY

        Overactive Bladder Stocks Recent News

        Date Stock Title
        May 10 URGN UroGen Pharma Q1 2024 Earnings Preview
        May 10 MDT Here's How Medtronic (MDT) Is Placed Ahead of Q4 Earnings
        May 9 MDT Medtronic Recognized for Health Monitoring Innovation in 8th Annual MedTech Breakthrough Awards Program
        May 9 MDT Medtronic: Managing Her Diabetes ‘Runner’s High’
        May 9 MDT Medtronic to announce financial results for its fourth quarter and full fiscal year 2024
        May 8 MDT 10 Future Dividend Kings in the Next 5 Years or Less
        May 8 MDT National Vision (EYE) Q1 Earnings Top Estimates
        May 7 MDT Medtronic’s renal denervation system receives approval in China
        May 7 MDT Medtronic wins approval to sell renal denervation device in China
        May 6 MDT Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing
        May 6 MDT Unlocking Longevity. Can Healthcare Technology Help People Achieve Quality and Quantity?
        May 6 MDT Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes
        May 5 URGN New Real-World Retrospective Analysis Presented at AUA 2024 Reports 86% Recurrence-Free Survival (RFS) at 24 Months with JELMYTO® Across All Studied Patient and Disease Characteristics in Cohort of Responders to Induction Therapy
        May 4 URGN UroGen Announces Results from ATLAS Showing Robust UGN-102 Durability of Response in New and Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer at AUA 2024
        May 4 URGN New Real-World Study on Retrograde Instillation of JELMYTO® for Treatment of Low-Grade Upper Tract Urothelial Cancer Reports Similar Complete Response Rate and Lower Stricture Rate Compared to OLYMPUS Pivotal Trial
        Related Industries: Biotechnology Medical Devices
        Related Stock Lists: Medicine Ablation Ablation Products Advanced Energy Antineoplastic Drugs Atrial Fibrillation Biologic Product Biologic Products Biopharmaceutical Bladder Cancer Bone Botulinum Toxin Bypass Cancer Carcinoma Cardiac Electrophysiology Catheter Chemotherapy Chronic Pain Cordis
        Overactive Bladder

        Overactive bladder (OAB) is a condition in which the bladder muscles contract uncontrollably, causing a sudden and frequent urge to urinate. People with OAB may also experience urinary incontinence, or the inability to control the release of urine. OAB is a common condition that affects millions of people worldwide. Treatment options include lifestyle changes, medications, and in some cases, surgery.

        Browse All Tags